Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen Deprivation Therapy: Post Hoc Analysis of Phase 3 LATITUDE Study


Matsubara N., Chi K. N. , ÖZGÜROĞLU M., Rodriguez-Antolin A., Feyerabend S., Fein L., ...Daha Fazla

EUROPEAN UROLOGY, cilt.77, ss.494-500, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 77 Konu: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.eururo.2019.11.021
  • Dergi Adı: EUROPEAN UROLOGY
  • Sayfa Sayıları: ss.494-500

Özet

Background: LATITUDE, a randomized, double-blind trial, compared abiraterone acetate and prednisone (AAP) + androgen deprivation therapy (ADT) versus placebo (PBO) + ADT in high-risk metastatic castration-sensitive prostate cancer (mCSPC).